Zhou, Yi <br/><br/>
Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge.  [electronic resource] 

 -  International immunopharmacology  Jul 2017 
 - 159-168 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2017.04.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5-Methoxypsoralen<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Cell Survival--drug effects<br/>Cyclooxygenase 2--metabolism<br/>Cytokines--metabolism<br/>Janus Kinase 1--metabolism<br/>Janus Kinase 2--metabolism<br/>Lipopolysaccharides<br/>Male<br/>Methoxsalen--analogs & derivatives<br/>Mice<br/>Mice, Inbred ICR<br/>Nitric Oxide Synthase Type II--metabolism<br/>RAW 264.7 Cells<br/>Reactive Oxygen Species--metabolism<br/>STAT1 Transcription Factor--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Shock--drug therapy